{"groups":[{"description":"Patients receive glutamine PO BID. Courses repeat every 28 days for 4 months in the absence of disease progression or unacceptable toxicity.\n\nglutamine: Dose of 15 grams twice times daily (to equal 30 grams a day) for a period of 4 months.\n\nquality-of-life assessment: Ancillary studies","id":"FG000","title":"Arm I (Preventative Nutritional Supplementation)"},{"description":"Patients receive placebo PO BID. Courses repeat every 28 days for 4 months in the absence of disease progression or unacceptable toxicity.\n\nquality-of-life assessment: Ancillary studies\n\nplacebo: Given PO","id":"FG001","title":"Arm II (Placebo)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"5"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"5"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}